A comparison of two treatment regimens of ceftriaxone in late Lyme disease

Wiener Klinische Wochenschrift

Volumn 117, Issue 11-12, 2005, Pages 393-397

  Dattwyler, Raymond J ^a   Wormser, Gary P ^a   Rush, Thomas J ^b   Finkel, Michael F ^c   Schoen, Robert T ^d   Grunwaldt, Edgar ^b   Franklin, Michael ^b   Hilton, Eileen ^e   Bryant, Gary L ^f   Agger, William A ^f   Maladorno, Dionigi ^g  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Cleveland Clinic Florida ^*

^c DEPARTMENT OF COLORECTAL SURGERY   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^f GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

^g HOFFMANN LA ROCHE INC   (United States)

Author keywords

Borrelia burgdorferi; Ceftriaxone; Lyme disease

Indexed keywords

CEFTRIAXONE;

ARTICLE; BORRELIA BURGDORFERI; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SEROLOGY; SIDE EFFECT; TREATMENT FAILURE;

EID: 23844485931     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-005-0361-8     Document Type: Article

References (15)

1. Steere AC (1989) Lyme disease. N Engl J Med 321: 586-596
2. Luft BJ, Steinman CR, Schubach WH, et al (1992) Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection. JAMA 267: 1364-1367
3. Nadelman RB, Pavia CS, Magnarelli LA, Wormser GP (1990) Isolation of Borrelia burgdorferi from the blood of seven patients with Lyme disease. Am J Med 88: 21-26
4. Rahn DW (1991) Lyme disease: clinical manifestations, diagnosis, and treatment. Semin Arthritis Rheum 20: 201-218
5. Dattwyler DJ, Halperin JJ, Volkman DJ, Luft BJ (1988) Treatment of late Lyme borreliosis - Randomized comparison of ceftriaxone and penicillin. Lancet i: 1191-1194
6. Wormser GP, Nadelman RB, Dattwyler RJ, et al (2000) Infectious Diseases Society of America Practice Guidelines for the Treatment of Lyme Disease. Clin Infect Dis 31 [Suppl 1]: 1-14
7. Russell H, Sampson JS, Schmid GP, Wilkinson HW, Plikaytis B (1984) Enzyme-linked immunoabsorbent assay and indirect immunofluorescence assay for Lyme disease. J Infect Dis 149: 465-470
8. Centers for Disease Control and Prevention (1995) Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 44: 590-591
9. Dattwyler RJ, Halperin JJ, Pass H, Luft BJ (1987) Ceftriaxone as effective therapy for refractory Lyme disease. J Infect Dis 155: 1322-1325
10. Logigian EL, Kaplan RF, Steere AC (1999) Successful treatment of Lyme encephalopathy with intravenous ceftriaxone. J Infect Dis 180: 377-383
11. Brown SL, Hansen SL, Langone JJ (1999) Role of serology in the diagnosis of Lyme disease. JAMA 282: 62-66
12. Logigian EL, Kaplan RF, Steere AC (1990) Chronic neurologic manifestations of Lyme disease. N Engl J Med 323: 1438-1444
13. Steere AC, Levin RE, Molloy PJ, Kalish RA, Abraham JH 3rd, Liu NY, Schmid CH (1994) Treatment of Lyme arthritis. Arthritis Rheum 37: 878-888
14. Shadick NA, Phillips CB, Logigian EL, Steere AC, Kaplan RF, Berardi VP, et al (1994) The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med 121: 560-567
15. Sigal LH (1994) Persisting complaints attributed to chronic Lyme disease: possible mechanisms and implications for management. Am J Med 96: 365-374